Objectives To describe the global trends of pulmonary nontuberculous mycobacteria (NTM)
infection and disease. Methods A systematic review of studies including culture-based NTM …

Infections caused by non-tuberculous mycobacteria (NTM) are increasing globally and are
notoriously difficult to treat due to intrinsic resistance of these bacteria to many common …

Tuberculosis (TB) remains one of the deadliest infectious diseases in human history,
prevailing even in the 21st century. The causative agents of TB are represented by a group …

Background Nontuberculous mycobacteria (NTM) are highly abundant in soil, dust, and
water sources, making human–pathogen contact frequent and recurrent. NTM represents …

Non-tuberculous mycobacteria (NTM) are ubiquitously present in the environment, but NTM
diseases occur infrequently. NTM are generally considered to be less virulent than …

Nontuberculous mycobacteria, particularly the Mycobacterium avium complex (MAC)
bacteria, are increasingly recognized as opportunistic pathogens of humans. As a result …

The definition of a genus has wide-ranging implications both in terms of binomial species
names and also evolutionary relationships. In recent years, the definition of the genus …

Background: The predominant species in clinical Enterobacter isolates is E. hormaechei.
Many articles, clinicians, and GenBank submissions misname these strains as E. cloacae …

The prevalence of nontuberculous mycobacteria (NTM) pulmonary diseases has been
increasing worldwide. NTM consist of approximately 200 species and distinguishing …

Pathogenic mycobacteria pose a sustained threat to global human health. Recently,
cytochrome bcc complexes have gained interest as targets for antibiotic drug development …